Article
Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials.
British journal of clinical pharmacology - 1 Oct 2010
Gueorguieva Ivelina, Jackson Kimberley, Wrighton Steven A, Sinha Vikram P, Chien Jenny Y
Abstract excerpt
AIMS: To develop a population pharmacokinetic model to describe the pharmacokinetics of desipramine in healthy subjects, after oral administration of a 50mg dose. Additional objectives were to develop a semi-mechanistic population pharmacokinetic model for desipramine, which allowed simulation of CYP2D6-mediated inhibition, when using desipramine as a probe substrate, and to evaluate certain study design...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
